Skip to main content
ProGen, Co,, LTD. logo

ProGen, Co,, LTD. — Investor Relations & Filings

Ticker · 296160 ISIN · KR7296160005 KO Manufacturing
Open in API
Filings indexed 153 across all filing types
Latest filing 2025-03-31 Remuneration Information
Country KR South Korea
Listing KO 296160

About ProGen, Co,, LTD.

https://progen.co.kr

ProGen is an R&D-focused biopharmaceutical company dedicated to developing innovative drugs for incurable diseases, with a primary focus on oncology, immune diseases, and metabolic disorders. The company specializes in creating novel protein-based immunotherapies and antibody therapeutics. Its research and development efforts are driven by proprietary technology platforms, including the NTIG (Neo Tri-ImmunoGlobulin) platform for next-generation multi-specific fusion proteins and the hyFc® platform for long-acting fusion proteins. These technologies enable the engineering of advanced bi-specific and multi-specific therapies designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to directors and employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a regulatory filing under the RNS category, as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2025-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board and management changes.
2025-03-31 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It provides detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) as part of the management reference materials for the upcoming AGM. Since this is a formal regulatory filing containing financial data and meeting materials, and it is not a standalone annual report or earnings release, it falls under the category of Proxy Solicitation & Information Statement (PSI) which typically includes the agenda and financial disclosures for shareholder meetings.
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) dated 2025.03.21. It provides a summary of the audit opinion and key financial data (assets, liabilities, profit/loss) as required by regulatory disclosure rules. Since it is a brief announcement of the audit report submission rather than the full, comprehensive audit report document itself, it falls under the category of a Report Publication Announcement. FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'ProGen' (주식회사 프로젠) for the fiscal year ending December 31, 2024. It includes the independent auditor's report from Samil PricewaterhouseCoopers, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes (주석). This is a comprehensive financial audit document, not an annual report (10-K) which typically includes management discussion and analysis (MD&A) and business overviews, nor is it a short announcement. Therefore, it is classified as an Audit Report. FY 2024
2025-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Progen Co., Ltd. It contains the meeting agenda, details on board/management appointments, financial statements, and proposed changes to the articles of incorporation. This document is a formal proxy statement/notice sent to shareholders to inform them of the upcoming meeting and request their votes on specific agenda items. In the context of the provided filing categories, this fits the definition of a Proxy Solicitation & Information Statement.
2025-03-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.